Schedule 13G ownership disclosure
EYEGATE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 30233M503
Event date: 2021-08-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 460,978
- Percent of class
- 3.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-043647
- Form type
- SC 13G
- Filer
- KIORA PHARMACEUTICALS INC
- CIK
- CIK 1372514
- Filed
- Aug 18, 2021
- Reporting period
- Aug 09, 2021
- Description
- Schedule 13G beneficial ownership